ANEI honours Dr MI Sahadulla with Lifetime Achievement Award

IMT News Desk
IMT News Desk
· 2 min read

With nearly five decades of experience in healthcare management, Dr Sahadulla has been instrumental in establishing KIMSHEALTH as a trusted name in India and the Middle East

Dr MI Sahadulla, Chairman and Managing Director, KIMSHEALTH, has been conferred with the prestigious Lifetime Achievement Award by the Association of Nurse Executives India (ANEI) in recognition of his exceptional contributions to the healthcare sector in India.

The award was presented by Capt Ajitha Nair, National President, ANEI, during the 5th Annual Flagship Event held in Kochi, in the presence of esteemed dignitaries and healthcare leaders. Established to serve as an inclusive and collective voice for nurses across domains from education to clinical practice, ANEI acknowledged Dr Sahadulla’s unparalleled impact on the healthcare ecosystem.

With nearly five decades of experience in healthcare management, Dr Sahadulla has been instrumental in establishing KIMSHEALTH as a trusted name in India and the Middle East. His unwavering commitment to patient safety, quality care, and upholding patient rights has not only elevated KIMSHEALTH’s reputation but also set benchmarks for the industry at large.

Dr Sahadulla has been a steadfast advocate for a culture rooted in empathy, ethics, excellence, and empowerment within the healthcare workforce. His unwavering commitment to fostering a supportive environment for healthcare professionals has left a lasting and meaningful legacy.

Dr Sahadulla also serves as the National President of the Association of Healthcare Providers of India (AHPI), continuing his advocacy for accessible, high-quality healthcare for all.

Read Next

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care
News
July 17, 2026

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care

Menthra, an AI-powered emotional wellbeing platform, today announced the launch of Menthra Care in India, expanding its platform to connect users with verified therapists, coaches, licensed clinical professionals and care organisations when they need support beyond an AI companion. The launch follows Menthra’s India debut in June, which saw tens of thousands of users join […]
Article by: IMT News Desk
IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care
News
July 17, 2026

IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region. At his opening […]
Article by: IMT News Desk
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk